Preface |
|
v | |
Contributors |
|
xi | |
|
Part I Updated Blood Processing and Handling Strategies |
|
|
|
1 Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation |
|
|
3 | (20) |
|
|
|
|
|
2 A Protocol for the Preparation of Cryoprecipitate and Cryo-depleted Plasma for Proteomic Studies |
|
|
23 | (8) |
|
|
|
|
3 Preparation of Platelet Concentrates for Research and Transfusion Purposes |
|
|
31 | (14) |
|
|
|
|
Part II Updated Fractionation Strategies for In-depth Blood Proteome Analysis |
|
|
|
4 Bead-Based and Multiplexed Immunoassays for Protein Profiling via Sequential Affinity Capture |
|
|
45 | (10) |
|
|
|
|
5 Affinity Proteomics for Fast, Sensitive, Quantitative Analysis of Proteins in Plasma |
|
|
55 | (8) |
|
|
|
|
6 Characterization of the Low-Molecular-Weight Human Plasma Peptidome |
|
|
63 | (18) |
|
|
|
7 In-Depth, Reproducible Analysis of Human Plasma Using IgY 14 and SuperMix Immunodepletion |
|
|
81 | (22) |
|
|
|
|
|
8 Low-Molecular-Weight Plasma Proteome Analysis Using Top-Down Mass Spectrometry |
|
|
103 | (16) |
|
|
|
|
|
9 Identification of Post-Translational Modifications from Serum/Plasma by Immunoaffinity Enrichment and LC-MS/MS Analysis Without Depletion of Abundant Proteins |
|
|
119 | (8) |
|
|
|
|
|
10 Identification of Core-Fucosylated Glycoproteome in Human Plasma |
|
|
127 | (14) |
|
|
|
|
|
Part III Updated Proteome Analysis of Blood Cell Components, Vesicles, and Blood-related Fluids |
|
|
|
11 Proteomic Analysis of Blood Extracellular Vesicles in Cardiovascular Disease by LC-MS/MS Analysis |
|
|
141 | (10) |
|
|
|
|
|
|
|
12 Targeted Approach for Proteomic Analysis of a Hidden Membrane Protein |
|
|
151 | (22) |
|
|
|
|
|
|
13 Red Blood Cells in Clinical Proteomics |
|
|
173 | (10) |
|
|
|
|
14 High-Throughput Quantitative Lipidomics Analysis of Nonesterified Fatty Acids in Plasma by LC-MS |
|
|
183 | (10) |
|
|
|
|
15 Simultaneous Enrichment of Plasma Extracellular Vesicles and Glycoproteome for Studying Disease Biomarkers |
|
|
193 | (10) |
|
|
|
16 Lipidomics of Human Blood Plasma by High-Resolution Shotgun Mass Spectrometry |
|
|
203 | (10) |
|
|
|
|
17 Proteomics Analysis of Circulating Serum Exosomes |
|
|
213 | (16) |
|
|
|
|
|
Part IV Antibody-based Discovery and Targeted Proteomics |
|
|
|
18 High-Density Serum/Plasma Reverse Phase Protein Arrays |
|
|
229 | (10) |
|
|
|
|
|
|
|
19 Antibody Colocalization Microarray for Cross-Reactivity-Free Multiplexed Protein Analysis |
|
|
239 | (24) |
|
|
|
|
|
20 Surface Profiling of Extracellular Vesicles from Plasma or Ascites Fluid Using DotScan Antibody Microarrays |
|
|
263 | (40) |
|
|
|
|
|
|
|
|
|
|
|
Richard I. Christopherson |
|
|
21 Serum Profiling for Identification of Autoantibody Signatures in Diseases Using Protein Microarrays |
|
|
303 | (16) |
|
|
|
|
|
Part V Developments in Discovery and Targeted Proteomics |
|
|
|
22 Quantitative Comparisons of Large Numbers of Human Plasma Samples Using TMT10plex Labeling |
|
|
319 | (20) |
|
|
|
|
|
|
23 Efficient Quantitative Comparisons of Plasma Proteomes Using Label-Free Analysis with MaxQuant |
|
|
339 | (14) |
|
|
|
|
|
|
24 Blood and Plasma Proteomics: Targeted Quantitation and Posttranslational Redox Modifications |
|
|
353 | (20) |
|
|
|
|
|
|
25 SWATH Mass Spectrometry for Proteomics of Non-Depleted Plasma |
|
|
373 | (12) |
|
|
|
26 Shotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung Cancer |
|
|
385 | (10) |
|
|
|
|
27 High-Throughput Parallel Proteomic Sample Preparation Using 96-Well Polyvinylidene Fluoride (PVDF) Membranes and C18 Purification Plates |
|
|
395 | (8) |
|
|
|
28 Targeted Quantification of the Glycated Peptides of Human Serum Albumin |
|
|
403 | (14) |
|
|
|
Mashanipalya G. Jagadeeshaprasad |
|
|
|
29 Absolute Quantification of Middle- to High-Abundant Plasma Proteins via Targeted Proteomics |
|
|
417 | (16) |
|
|
|
Part VI Developments in Biomarker Discovery |
|
|
|
30 A Highly Automated Shotgun Proteomic Workflow: Clinical Scale and Robustness for Biomarker Discovery in Blood |
|
|
433 | (18) |
|
|
|
|
|
|
31 Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation |
|
|
451 | (16) |
|
|
|
|
|
|
32 Metabolomics Toward Biomarker Discovery |
|
|
467 | (10) |
|
|
|
33 Plasma Biomarker Identification and Quantification by Microparticle Proteomics |
|
|
477 | (10) |
|
|
|
34 Bronchoalveolar Lavage: Quantitative Mass Spectrometry-Based Proteomics Analysis in Lung Diseases |
|
|
487 | (8) |
|
|
|
35 Protein Multiplexed Immunoassay Analysis with R |
|
|
495 | (44) |
|
Appendix A Standard Operating Procedures for Plasma Collection in Clinical Research |
|
539 | (4) |
Appendix B Standard Operating Procedures for Serum Collection in Clinical Research |
|
543 | (4) |
Appendix C Reference Ranges for Blood Tests Are 1Sorted by Mass and Molarity |
|
547 | (2) |
Index |
|
549 | |